UFMG applied a patent for the development process and the use of a new medical device that informs the gestational age of a newborn based on the optical properties of the skin.
The Universidade Federal de Minas Gerais (UFMG) applied a patent for the process and the use of a new device that informs the gestational age of a newborn, based on the optical properties of the skin. The project is being coordinated by Zilma Reis, Professor in the Department of Gynecology and Obstetrics of the Faculty of Medicine of UFMG. The product is a result of the Newborn Skin-age Project, sponsored by the Bill & Melinda Gates Foundation and Fapemig. The goal is to be a technological innovation focused on the challenge of reducing immediate and future complications related to premature birth, the main cause of death in low- and middle-income countries, and disabling health conditions in high-income countries. According to the coordinator, beyond the patent registry, a multicenter study is planned, in which different hospitals in Brazil, the United States, Portugal and Africa countries will test the device.
Site da Faculdade de Medicina da UFMG, Publicado em: Externas • Notícias – 17 de novembro de 2016